Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site

Zsὁfia Iglὁi, Jans Velzing, Janko van Beek, David van de Vijver, Georgina Aron, Roel Ensing, Kimberley Benschop, Wanda Han, Timo Boelsums, Marion Koopmans, Corine Geurtsvankessel, Richard Molenkamp
doi: https://doi.org/10.1101/2020.11.18.20234104

Article Information

doi 
https://doi.org/10.1101/2020.11.18.20234104
History 
  • November 20, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Zsὁfia Iglὁi1,*,
  2. Jans Velzing1,
  3. Janko van Beek1,
  4. David van de Vijver1,
  5. Georgina Aron1,
  6. Roel Ensing2,
  7. Kimberley Benschop3,
  8. Wanda Han3,
  9. Timo Boelsums2,
  10. Marion Koopmans1,
  11. Corine Geurtsvankessel1 and
  12. Richard Molenkamp1
  1. 1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
  2. 2Public Health Service Rotterdam-Rijnmond, Rotterdam, The Netherlands
  3. 3Centre for infectious Disease Control (Cib), National Public Health Institute (RIVM), Bilthoven, The Netherlands
  1. ↵*Corresponding author; email:z.igloi{at}erasmusmc.nl; alternate corresponding author:r.molenkamp{at}erasmusmc.nl
Back to top
Posted November 20, 2020.
Download PDF
Data/Code
Email
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site
Zsὁfia Iglὁi, Jans Velzing, Janko van Beek, David van de Vijver, Georgina Aron, Roel Ensing, Kimberley Benschop, Wanda Han, Timo Boelsums, Marion Koopmans, Corine Geurtsvankessel, Richard Molenkamp
medRxiv 2020.11.18.20234104; doi: https://doi.org/10.1101/2020.11.18.20234104
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area